the challenges of utilizing registry datafor regulatory

16
The challenges of Utilizing Registry Data For Regulatory Use ‐ Academic View The challenges of Utilizing Registry Data For Regulatory Use ‐ Academic View Ryo Inuzuka, MD PhD Hikoro Matsui, MD PhD 1 Sung‐Hae Kim, MD Satoshi Yasukochi, MD 1.Department of Pediatrics, University of TokyoJapan 2.Department of Cardiology, Shizuoka Children’s Hospital, Japan 3.Nagano Children's Hospital On behalf of JPIC database working group

Upload: others

Post on 26-Apr-2022

6 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: The challenges of Utilizing Registry DataFor Regulatory

The challenges of Utilizing Registry Data For Regulatory Use

‐ Academic View

The challenges of Utilizing Registry Data For Regulatory Use

‐ Academic ViewRyo Inuzuka, MD PhD1、Hikoro Matsui, MD PhD1、Sung‐Hae Kim, MD2、Satoshi Yasukochi, MD3

1.Department of Pediatrics, University of Tokyo、Japan

2.Department of Cardiology, Shizuoka Children’s Hospital, Japan

3.Nagano Children's Hospital

On behalf of JPIC database working group

Page 2: The challenges of Utilizing Registry DataFor Regulatory

Utilization of Registry Data for Introduction of Pediatric Medical Devices

Utilization of Registry Data for Introduction of Pediatric Medical Devices

Registry dataAcademia

Data for regulatory use1. Data for Approval 2. Post Marketing Surveillance

(PMS)

Page 3: The challenges of Utilizing Registry DataFor Regulatory

An experience with PMS using registry data: TAVI registry

An experience with PMS using registry data: TAVI registry

TAVI Registry Individualdata

Existing surgical database≠ GPSP-compliant

(Good Post-marketing Study Practice)

Development of New database

PMDA: Pharmaceuticals and Medical Device Agency

Page 4: The challenges of Utilizing Registry DataFor Regulatory

• Small market due to the rarity of the diseases

• Requires variable kinds and sizes of devices

• Difficult to perform clinical trials due to small number of patients and too many institutions

Features of Pediatric Medical Device in JapanFeatures of Pediatric Medical Device in Japan

Cost reduction of PMS is crucial

Page 5: The challenges of Utilizing Registry DataFor Regulatory

JPIC‐Registry PMSfor pediatric medical device

Cost reduction of PMS using JPIC‐RegistryCost reduction of PMS using JPIC‐Registry

Development of universal platform for PMS on pediatric medical devicesNeeds to be compliant with GPSP(Good Post-marketing Study Practice)

JPIC: Japanese society of Pediatric Interventional CardiologyJPIC: Japanese society of Pediatric Interventional Cardiology

Page 6: The challenges of Utilizing Registry DataFor Regulatory

• Pediatric interventional cardiac catheter procedures from ~90 institutions

• 4000 cases/year (almost all pediatric cases in Japan)

• 140 variables/case

• Meticulous collection of complications

JPIC registry (2013‐)JPIC registry (2013‐)Operated by National clinical database (NCD)

Page 7: The challenges of Utilizing Registry DataFor Regulatory

1085

166

27493682 3993 4311

101 56311 343 383

493

0

1000

2000

3000

4000

5000

6000

2014 2015 2016 2017

Ablation‐EDC/individualdata

Ablation‐QN/institutionaldata

Intervention‐EDC/individualdata

Intervention‐QN/institutionaldata

JPIC‐RegistryJPIC‐Registry

Page 8: The challenges of Utilizing Registry DataFor Regulatory

✓ Benchmarking function✓ Explanation to patients regarding complication rate✓ Operator / Institutional certification for new devices✓ Approval for new devices✓ Pre- and Post- marketing surveillance✓ Multi-institutional study

✓ Benchmarking function✓ Explanation to patients regarding complication rate✓ Operator / Institutional certification for new devices✓ Approval for new devices✓ Pre- and Post- marketing surveillance✓ Multi-institutional study

Aims of JPIC‐RegistryAims of JPIC‐Registry

Academic Use

Regulatory Use 

Page 9: The challenges of Utilizing Registry DataFor Regulatory

Contractual relationship of postmarketing database surveyContractual relationship of 

postmarketing database survey

Healthcare facility DB holder Pharmaceutical company

Indirect contract with healthcare facility

Work of data collection by healthcare facilities can become a hidden cost!

Data input(almost voluntary)

Page 10: The challenges of Utilizing Registry DataFor Regulatory

Challenge 1: survey itemsChallenge 1: survey items• Too many items increase the cost

(input/error check/query)

• Too different from academic survey items

• Includes information on medical device failure

• Needs to be fit into database format

• Longer follow-up (until discharge/1m⇒3y)

Survey items need to be minimized by cooperation among PMDA, industry and academia!

Page 11: The challenges of Utilizing Registry DataFor Regulatory

Challenge 2: SOP (Standard Operating Procedures)Challenge 2: SOP (Standard Operating Procedures)

• Establishment/management of registry• Data cleaning• Coding• Security• Data backup and recovery• Quality control of healthcare data from information sources• Data management• Quality assurance• Storage of records• Education and training

SOPs required according to GPSP

These need to be prepared with the aid of CRO (⇒initial cost).

Page 12: The challenges of Utilizing Registry DataFor Regulatory

Period between procedure and data entry is 0d-1y for academic use.

⇔Data needs to be entered in timely manner (in several wks) for PMS.

Finding “time 0” is important to send reminders to healthcare facilities.

Idea is to use shipping records to trigger reminders for data entry

Challenge 3: Progress managementChallenge 3: Progress managementProcedure

30d 60d 1y 2y 3yTime 0

Page 13: The challenges of Utilizing Registry DataFor Regulatory

Challenge 4: Patient ConsentChallenge 4: Patient Consent

Academic registry

Opt-out

Registry PMS

Non-academic use=Opt-in? Normal PMS

DB

DB

unnecessary

Legal framework for registry PMS may be needed

Page 14: The challenges of Utilizing Registry DataFor Regulatory

An example of pediatric medicaldevice used as off‐label: static BASAn example of pediatric medicaldevice used as off‐label: static BAS

589 cases/3yrs 294 cases/3yrs

Rashkind BAS: On-label use static BAS: Off-label use

Balloon atrial septostomy

Page 15: The challenges of Utilizing Registry DataFor Regulatory

Specify clinical situation (Why) e.g. cases in which Rashkind BAS was ineffective

Identify concomitantly used devices (How) e.g. Double balloon/stenting/Brockenbrough etc

Confirm safety i.e. difference in complication rate between off-label v.s. on-label use

static BAS survey for device approvalstatic BAS survey for device approvalSupported by Ministry of Health, Labor and Welfare

Page 16: The challenges of Utilizing Registry DataFor Regulatory

SummarySummary

It’s a matter of how to balance the cost and the benefit!